Researchers have created an oral medication that could work alone or with GLP-1 drugs to improve metabolic health while ...
Berberine is an alkaloid compound found in plants with over 400-500 species. It has recently become popular as a potential ...
The class of GLP-1 agonist medications act by lowering the appetite with applications way beyond diabetes. These medicines ...
Regular injections could soon be a thing of the past for two different ailments, as a new pill arises as an alternative to Ozempic, and a skin cream could replace insulin shots for diabetics.
Usage of GLP-1 medications has increased over the past 18 months, with highest adoption among women and adults aged 50-64, ...
In early 2025, the British Medical Journal (BMJ) reported 82 UK deaths from adverse reactions to semaglutide and tirzepatide, ...
As a work of reportage, Off the Scales does a wonderful job of explaining the origins of Ozempic and other GLP-1 drugs and ...
Australia’s drug regulator, Therapeutic Goods Administration, has issued a new safety warning for Ozempic and similar ...
As access expands, doctors advise it must still be used as a chronic disease treatment, not a quick cosmetic fix.
Eli Lilly announced trial results for its weight-loss medication, orforglipron, in August. Orforglipron is a once-daily oral GLP-1 pill being studied for the treatment of type 2 diabetes and obesity, ...
The slew of suddenly curve-less celebrities flaunting rail-thin frames is having a dangerous impact on women like Emily James ...
New Scientist on MSN
Daily pill could offer alternative to weight-loss injections
Orforglipron, a GLP-1 drug taken as a pill, achieved positive results in people with obesity and type 2 diabetes, although it seems less effective than injectable drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results